
CPE's Orège raises €20.1m in IPO
Orège, the French sludge treatment company backed by Climate Change Capital Private Equity (CPE) and Oraxys, has raised €20.1m in a flotation of 6.2 million new shares on the NYSE Euronext Paris, valuing the company at €57.7m.
The shares sold at a price of €3.24 per unit and the offering comprised a global placement of 6 million shares allocated to institutional investors, as well as an open price offer of around 232,000 shares offered to the French public.
Following the IPO, CPE remains one of the largest shareholders of Orège. The firm owns a 22.7% stake in the company, equivalent to four million shares.
Luxembourg-based venture capital firm Oraxys owns a 6.2% stake in Orège, while Inocap holds 6.4%.
An over-allotment option of 543,500 shares has been granted by CPE and Oraxys, who will sell the units if the option is implemented for a total of €1.8m.
Inocap first invested in Orège in June 2008. Following this, CPE and Oraxys contributed a further €8m to the company in July 2011, with CPE providing €6m of the sum and Oraxys footing the remainder, according to unquote" data.
Société Générale has been appointed lead manager for the flotation, as well as joint bookrunner alongside Invest Securities.
Company
Orège is based in Jouy-en-Josas, with an additional research and development centre in Aix-en-Provence. Orège employs 40 staff and was founded in 2005.
The company provides effluent and sludge treatment technology to industrial and municipal customers. Its products aim to comply with new regulatory and environmental requirements.
Markets targeted by Orège include oil and gas, petrochemicals, agricultural food production and local authorities. The company recorded turnover of €1m for 2012, as well as an operating loss of €1.5m.
People
Pascal Gendrot is the CEO of Orège. Alex Betts is a managing director at CPE.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater